Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Dose Dexamethasone for CINV in Elderly
NCT03177317Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- May 2017
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in chemotherapy-induced nausea and vomiting (CINV), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Complete Response at 2 weeks. Started May 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT03177317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177317.